Details of the Drug | DrugMAP

General Information of Drug (ID: DMYSI9J)

Drug Name	US10149841, Compound 19
Synonyms	SCHEMBL19808937; BDBM306799; US10149841, Compound 19
Drug Type	Small molecular drug
Structure
Structure	3D MOL			2D MOL
#Ro5 Violations (Lipinski): 0	Molecular Weight (mw)			316.31
	Logarithm of the Partition Coefficient (xlogp)			2.5
	Rotatable Bond Count (rotbonds)			5
	Hydrogen Bond Donor Count (hbonddonor)			3
	Hydrogen Bond Acceptor Count (hbondacc)			6
Chemical Identifiers	Formula C16H16N2O5 IUPAC Name 2-[[5-(2,4-dimethylphenoxy)-3-hydroxypyridine-2-carbonyl]amino]acetic acid Canonical SMILES CC1=CC(=C(C=C1)OC2=CC(=C(N=C2)C(=O)NCC(=O)O)O)C InChI InChI=1S/C16H16N2O5/c1-9-3-4-13(10(2)5-9)23-11-6-12(19)15(17-7-11)16(22)18-8-14(20)21/h3-7,19H,8H2,1-2H3,(H,18,22)(H,20,21) InChIKey NRYBEIHDIVNLGM-UHFFFAOYSA-N
Cross-matching ID	PubChem CID 134204785 TTD ID D0F0DX

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
HIF-prolyl hydroxylase 2 (HPH-2)	TT9ISBX	EGLN1_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Compound of 3-hydroxyl pyridine, preparation method thereof and pharmaceutical use thereof. US10149841.